Home Ideas This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene...

This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing

71

Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do.

Source: WIRED.com